✨ Your Portfolio is fetched and updated from zerodha.
Mid Pharmaceuticals

Laurus Labs Ltd.

LAURUSLABS

Market Cap
₹35,992 Cr.
P/E
100.45

Laurus Labs Ltd.

  • Laurus Labs
  • Neuland Laboratories
  • Alivus Life Sciences
  • TJI Pharma - Small Cap
FAQs on Laurus Labs Ltd. Shareprice

Laurus Labs has given lower returns compared to its competitors.
Laurus Labs has grown at ~36.27% over the last 2yrs while peers have grown at a median rate of 47.91%

Yes, Laurus Labs is expensive.
Latest PE of Laurus Labs is 100, while 3 year average PE is 70.38.
Also latest EV/EBITDA of Laurus Labs is 36.52 while 3yr average is 23.38.

View FAQ's On Business
Growth Table
  • Laurus Labs Ltd.
  • Neuland Laboratories
  • Alivus Life Sciences
Balance Sheet
  • Laurus Labs Ltd.
  • Neuland Laboratories
  • Alivus Life Sciences
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Laurus Labs Ltd.
  • Neuland Laboratories
  • Alivus Life Sciences
Cash Flow
  • Laurus Labs Ltd.
  • Neuland Laboratories
  • Alivus Life Sciences
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Laurus Labs Ltd.
  • Neuland Laboratories
  • Alivus Life Sciences
Quarterly Results
  • Laurus Labs Ltd.
  • Neuland Laboratories
  • Alivus Life Sciences
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF
FAQs on Laurus Labs Ltd. Financials

Balance sheet of Laurus Labs is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Laurus Labs is increasing.
Latest net debt of Laurus Labs is ₹2,405 Crs as of Mar-25.
This is greater than Mar-24 when it was ₹2,224 Crs.

The profit is oscillating.
The profit of Laurus Labs is ₹358 Crs for Mar 2025, ₹158 Crs for Mar 2024 and ₹785 Crs for Mar 2023

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Laurus Labs latest dividend payout ratio is 18.06% and 3yr average dividend payout ratio is 19.71%

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech